Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biotech Jim who wrote (2440)	4/19/1999 3:45:00 PM
From: IRWIN JAMES FRANKEL	Respond to of 10280

I have tried 3 times to post this on Yahoo - it must be down. Lehman - STRONG BUY -- reiterates strong buy, 1st quarter in line, strong outlook, current weakness is buying opportunity, target $145 Link: companysleuth.com ij

To: Biotech Jim who wrote (2440)	4/19/1999 3:48:00 PM
From: BMcV	Read Replies (1) \| Respond to of 10280

Yes, we're still ahead of the b$$tard: techstocks.com

To: Biotech Jim who wrote (2440)	4/19/1999 4:12:00 PM
From: j_fir2	Respond to of 10280

Biotech Jim: see #2425. Also the chart comparing SEPR to AZA: Maris suggested we dump SEPR for AZA--

To: Biotech Jim who wrote (2440)	4/19/1999 4:17:00 PM
From: Biomaven	Read Replies (3) \| Respond to of 10280

I wonder if Maris did the same for AZA based on the similar letter they received at just about the same time ... Somehow I suspect not. It's a pity this SEPR/Maris feud has developed to this extent. There's some fault on both sides, IMO. I think a significant part of this decline has been in sympathy with the pharmas - look at PFE, down 35 points in the past week or so. Well, now I know why I hold 2nd and 3rd tier biotech stocks as well as SEPR and BGEN. This hasn't generally been a real smart move for the last few years, but maybe things are changing. There's actually some strength lurking in the biotech basement, which is healthy for the sector in the long run. Peter